CN Stock MarketDetailed Quotes
300294 China Resources Boya Bio-pharmaceutical Group
- 31.22
- +0.42+1.36%
Market Closed Nov 29 15:00 CST
15.74BMarket Cap84.61P/E (TTM)
31.69High30.72Low55.87KlotVolume30.81Open30.80Pre Close174.59MTurnover1.11%Turnover Ratio66.28P/E (Static)504.25MShares41.8252wk High2.10P/B15.74BFloat Cap22.4552wk Low36.96Limit Up504.25MShs Float57.28Historical High24.64Limit Down3.15%Amplitude3.34Historical Low0.46Dividend TTM31.25Avg Price22.55KlotAsk1.47%Div YieldTTM100Lot Size30.53KlotBid
China Resources Boya Bio-pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -47.40%1.19B | -48.95%799.28M | -47.54%410.44M | -2.17%2.76B | 9.58%2.25B | 16.42%1.57B | 30.39%782.4M | 2.54%2.82B | -0.58%2.06B | -1.99%1.34B |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --14.36M | --54K | ---- |
| Cash received relating to other operating activities | 14.41%58.49M | 27.86%49.52M | 141.87%23.23M | 66.56%62.34M | 11.90%51.12M | 2.66%38.73M | 53.09%9.6M | -95.01%37.43M | -7.74%45.69M | -8.21%37.73M |
| Cash inflows from operating activities | -46.03%1.24B | -47.10%848.79M | -45.24%433.67M | -1.76%2.82B | 9.63%2.3B | 16.04%1.6B | 30.62%792M | -17.96%2.87B | -0.74%2.1B | -2.17%1.38B |
| Goods services cash paid | -63.82%333.85M | -67.05%209.86M | -63.84%106.96M | 3.96%1.06B | 21.60%922.67M | 27.84%636.95M | 32.06%295.81M | 16.16%1.02B | 993.20%758.75M | 267.98%498.23M |
| Staff behalf paid | -18.21%218.23M | -9.17%153.62M | -2.80%94.45M | 5.08%337.48M | 4.89%266.83M | -7.69%169.13M | -18.37%97.17M | 9.34%321.18M | 10.94%254.39M | 15.53%183.21M |
| All taxes paid | -34.48%126.08M | -44.58%76.33M | -44.93%29.05M | 3.34%250.39M | 2.28%192.43M | 15.07%137.72M | -25.60%52.75M | 25.64%242.3M | 40.98%188.14M | 29.22%119.69M |
| Cash paid relating to other operating activities | -23.59%303.35M | -26.22%197.32M | -35.81%79.33M | -22.99%537.75M | -24.22%397M | -24.18%267.46M | -27.40%123.6M | -12.34%698.25M | -21.41%523.91M | -23.69%352.75M |
| Cash outflows from operating activities | -44.83%981.51M | -47.40%637.13M | -45.59%309.79M | -4.21%2.18B | 3.12%1.78B | 4.97%1.21B | -2.55%569.32M | 5.56%2.28B | 82.67%1.73B | 176.81%1.15B |
| Net cash flows from operating activities | -50.08%262.41M | -46.17%211.66M | -44.37%123.87M | 7.59%641.73M | 39.44%525.71M | 71.88%393.18M | 905.46%222.68M | -55.67%596.44M | -67.87%377.01M | -77.04%228.75M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 19.94%4.68B | 12.82%3.95B | 60.00%800.01M | -0.16%6.84B | 14.76%3.9B | 2.98%3.5B | --500M | 354.58%6.85B | 500.06%3.4B | 853.94%3.4B |
| Cash received from returns on investments | 25.96%67M | 20.48%55.57M | 285.51%11.45M | 26.30%98.33M | 10.41%53.19M | -4.26%46.13M | --2.97M | 140.31%77.86M | 329.49%48.18M | 1,019.91%48.18M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 19.22%1.29M | 259.08%1.17M | 1,001.93%1.13M | 889.35%3.26M | 270.27%1.08M | 14.10%325.34K | 9.74%102.53K | -92.53%329.84K | 18.47%291.55K | 115.45%285.13K |
| Net cash received from disposal of subsidiaries and other business units | 200.18%109.43M | --109.43M | --109.43M | --269M | --36.45M | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 22.17%4.88B | 16.03%4.12B | 83.28%922.01M | 4.06%7.21B | 15.78%3.99B | 2.87%3.55B | 538,348.49%503.07M | 348.80%6.93B | 496.55%3.45B | 855.65%3.45B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 59.99%119.28M | -6.37%51.67M | -9.27%21.18M | -36.79%87.5M | -3.19%74.55M | 121.04%55.19M | 90.51%23.34M | 103.19%138.41M | 40.52%77.01M | -38.49%24.97M |
| Cash paid to acquire investments | 4.33%4.63B | -15.22%2.83B | 126.00%1.13B | -3.57%7.09B | 6.94%4.44B | -19.57%3.34B | -28.57%500M | 83.20%7.35B | 216.32%4.15B | 218.26%4.15B |
| Cash paid relating to other investing activities | --182M | ---- | ---- | --20M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 9.28%4.93B | -15.07%2.88B | 119.97%1.15B | -3.91%7.2B | 6.75%4.51B | -18.73%3.39B | -26.52%523.34M | 83.54%7.49B | 209.27%4.23B | 210.51%4.17B |
| Net cash flows from investing activities | 89.69%-53.56M | 698.86%1.23B | -1,030.62%-229.16M | 102.54%14.25M | 33.24%-519.77M | 121.27%154.53M | 97.15%-20.27M | 77.91%-560.22M | 1.29%-778.54M | 26.15%-726.51M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.92%2M | --2M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2M | --2M | ---- |
| Cash from borrowing | ---- | ---- | ---- | --22.15M | --22.15M | --22.15M | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | --5.24M | --5.24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -76.35%5.24M | -76.35%5.24M | ---- | 1,007.25%22.15M | 1,007.25%22.15M | --22.15M | ---- | -99.92%2M | -99.21%2M | ---- |
| Borrowing repayment | 0.00%22.15M | ---- | ---- | --22.15M | --22.15M | --22.15M | --22.15M | ---- | ---- | ---- |
| Dividend interest payment | 12.14%151.27M | 12.14%151.27M | ---- | 62.16%134.9M | 71.43%134.9M | 78.23%134.9M | ---- | 80.74%83.19M | 99.76%78.69M | 130.44%75.69M |
| Cash payments relating to other financing activities | -96.55%2.03M | -3.31%1.94M | -93.62%52.86K | 2,566.17%101.75M | 2,197.13%58.73M | 59.12%2M | 32.07%828.19K | -71.71%3.82M | -16.43%2.56M | -45.96%1.26M |
| Cash outflows from financing activities | -18.69%175.45M | -3.67%153.21M | -99.77%52.86K | 197.44%258.79M | 165.57%215.78M | 106.70%159.05M | 3,280.31%22.97M | -85.95%87.01M | -73.57%81.25M | -74.37%76.95M |
| Net cash flows from financing activities | 12.10%-170.21M | -8.08%-147.97M | 99.77%-52.86K | -178.39%-236.65M | -144.33%-193.63M | -77.92%-136.91M | -3,280.31%-22.97M | -104.18%-85.01M | -42.51%-79.25M | -59.21%-76.95M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | --6.97K | --6.97K | --485.54 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | 120.59%38.64M | 216.01%1.3B | -158.71%-105.35M | 959.40%419.33M | 60.96%-187.7M | 171.48%410.81M | 125.98%179.44M | -105.80%-48.79M | -246.04%-480.79M | -1,514.68%-574.7M |
| Add:Begin period cash and cash equivalents | 27.40%1.95B | 27.40%1.95B | 27.40%1.95B | -3.09%1.53B | -3.09%1.53B | -3.09%1.53B | -3.09%1.53B | 114.03%1.58B | 114.03%1.58B | 114.03%1.58B |
| End period cash equivalent | 48.09%1.99B | 67.31%3.25B | 7.87%1.84B | 27.40%1.95B | 22.24%1.34B | 93.25%1.94B | 92.43%1.71B | -3.09%1.53B | 2.94%1.1B | 43.04%1B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data